We are delighted to welcome you to the ESMO Asia Congress 2026 in Singapore, from 4 to 6 December 2026.
This premier meeting will bring together oncology professionals from across the Asia-Pacific region and beyond to explore the latest scientific and clinical advances in cancer care.
The congress will offer a high-quality scientific programme addressing the most prevalent cancer types in Asia, with a strong focus on state-of-the-art multidisciplinary care.
Participants will gain insights into key breakthroughs in molecular oncology, including advances in prognostication and risk-adapted treatment strategies.
Through interactive and multidisciplinary sessions, the programme will highlight the integration of emerging diagnostics, biomarker-driven approaches, targeted therapies, and artificial intelligence into clinical practice.
It will also address ongoing challenges in personalised cancer care, including rare cancers, perioperative treatments, and advanced therapeutic strategies, alongside patient-centred care and access to treatment across diverse Asian healthcare systems.
A strong emphasis will be placed on collaboration with leading international and Asia-Pacific oncology societies, fostering meaningful scientific exchange across regions and disciplines. The ESMO Pan-Asian Guidelines Adaptation (PAGA) sessions will remain a cornerstone of the programme, promoting best-practice standards and dialogue among global experts to improve patient outcomes.
The ESMO Asia Congress 2026 is for Asia, in Asia—a dynamic platform where regional and global oncology communities come together to share knowledge and shape the future of cancer care.
